In a recent editorial published in the Journal of Experimental Medicine, Cecilia Berin, PhD, discusses the current state of IgE-mediated food allergy treatments, targeting type 2 immune responses, and next steps for food allergy research and treatment development.
The presence of food-specific IgA antibodies in the gut does not prevent peanut or egg allergies from developing in children, according to a Northwestern Medicine-led study published in Science Translational Medicine.
Targeting internal proteins instead of spike proteins may be a promising strategy for monoclonal antibody therapy to combat SARS-CoV-2, the virus that causes COVID-19.
In the newly formed Center for Human Immunobiology, teams of interdisciplinary scientists and clinicians will work together to understand the immune system at the molecular level and translate new discoveries into cures for immune-regulated diseases.
Northwestern scientists have developed a new tool to harness immune cells from tumors to fight cancer rapidly and effectively.
Feinberg scientists including the lab of William Muller, MD, PhD, are investigating how regulating inflammation can be a pathway to treating a range of diseases.
A new Northwestern study has discovered a technique to help make immunomodulation more effective, potentially improving treatment for type 1 diabetes.
Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.
A new Northwestern Medicine study has uncovered herpes’ sneaky strategy for infecting the nervous system, opening a path to long-needed vaccine development for the virus.
Coronavirus vaccines and prior coronavirus infections can provide broad immunity against other, similar coronaviruses, paving the way for future universal coronavirus vaccines.